Endocrinology Guideline-based starting estimate
Insulin TDD Estimator
Estimates total daily dose (TDD) of insulin for new insulin starts. 50% basal, 50% bolus split.
References
- NICE NG28. Type 2 diabetes in adults: management. 2022.
- Joint British Diabetes Societies (JBDS). Management of Hyperglycaemia in Adults in the Inpatient Setting. 2021.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Insulin Glargine · Long-Acting Insulin Analogue (Basal)
- Insulin Aspart · Rapid-Acting Insulin Analogue (Bolus)
- Tirzepatide · Dual GIP/GLP-1 Receptor Agonist — Type 2 Diabetes / Obesity
- Isophane (NPH) insulin · Intermediate-acting insulin
- Dopamine (ICU — Vasopressor/Inotrope) · Catecholamine (Dose-Dependent Vasopressor/Inotrope)
- Insulin (IV Infusion — ICU Glucose Control) · Insulin — ICU Glucose Management
Pathways
- Diabetic Ketoacidosis (DKA) · JBDS 2013 / Joint British Diabetes Societies; NICE NG17
- Type 2 Diabetes Management · NICE NG28 2022
- Hyperthyroidism Management · BTA / ETA 2018
- Adrenal Insufficiency · Society of Endocrinology / ESE 2016
- Pituitary Apoplexy · ENEA 2011 / Pituitary Society
- Hypercalcaemia Management · NICE / Endocrine Society
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.